TNFAIP2 SNPs are associated with prognosis and risk stratification in a variety of tumors (25, 26), including squamous cell carcinoma and gastric cancer, strongly suggesting their potential role in AML. This evidence concerns the gene TNFAIP2 and acute myeloid leukemia.